NO20065879L - Bisykliske heterosykler som HIV-integraseinhibitorer - Google Patents

Bisykliske heterosykler som HIV-integraseinhibitorer

Info

Publication number
NO20065879L
NO20065879L NO20065879A NO20065879A NO20065879L NO 20065879 L NO20065879 L NO 20065879L NO 20065879 A NO20065879 A NO 20065879A NO 20065879 A NO20065879 A NO 20065879A NO 20065879 L NO20065879 L NO 20065879L
Authority
NO
Norway
Prior art keywords
hiv integrase
integrase inhibitors
bicyclic heterocycles
hiv
compounds
Prior art date
Application number
NO20065879A
Other languages
English (en)
Norwegian (no)
Inventor
Yasutsugu Ueda
Jacques Banville
Margaret E Sorenson
John D Matiskella
Francis Beaulieu
B Narasimhulu Naidu
Michael A Walker
Roger Remillard
Serge Plamondon
Timothy P Connolly
Mark R Krystal
Carl Ouellet
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20065879L publication Critical patent/NO20065879L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20065879A 2004-05-28 2006-12-19 Bisykliske heterosykler som HIV-integraseinhibitorer NO20065879L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57551304P 2004-05-28 2004-05-28
US60337104P 2004-08-20 2004-08-20
US11/126,891 US7176196B2 (en) 2004-05-28 2005-05-11 Bicyclic heterocycles as HIV integrase inhibitors
PCT/US2005/016473 WO2005118593A1 (fr) 2004-05-28 2005-05-12 Heterocycles bicycliques servant d'inhibiteurs d'integrase du vih

Publications (1)

Publication Number Publication Date
NO20065879L true NO20065879L (no) 2007-02-20

Family

ID=35456854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065879A NO20065879L (no) 2004-05-28 2006-12-19 Bisykliske heterosykler som HIV-integraseinhibitorer

Country Status (27)

Country Link
US (2) US7176196B2 (fr)
EP (1) EP1749011B1 (fr)
JP (1) JP4874959B2 (fr)
KR (1) KR101097623B1 (fr)
AR (1) AR049124A1 (fr)
AT (1) ATE412656T1 (fr)
AU (1) AU2005250356C1 (fr)
BR (1) BRPI0511623A (fr)
CA (1) CA2568356C (fr)
CY (1) CY1110266T1 (fr)
DE (1) DE602005010690D1 (fr)
DK (1) DK1749011T3 (fr)
ES (1) ES2315875T3 (fr)
HK (1) HK1107343A1 (fr)
HR (1) HRP20090005T3 (fr)
IL (1) IL179455A (fr)
MX (1) MXPA06013835A (fr)
NO (1) NO20065879L (fr)
NZ (1) NZ551282A (fr)
PE (1) PE20060242A1 (fr)
PL (1) PL1749011T3 (fr)
PT (1) PT1749011E (fr)
RS (1) RS50700B (fr)
RU (1) RU2381228C2 (fr)
SI (1) SI1749011T1 (fr)
TW (1) TWI366567B (fr)
WO (1) WO2005118593A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115601B2 (en) 2004-05-18 2006-10-03 Bristol-Myers Squibb Company HIV integrase inhibitors
CN101146811B (zh) * 2005-03-31 2012-01-11 P.安杰莱蒂分子生物学研究所 Hiv整合酶抑制剂
US7494984B2 (en) * 2005-08-31 2009-02-24 Bristol-Myers Squibb Company Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors
US7939537B2 (en) 2005-10-04 2011-05-10 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. HIV integrase inhibitors
US7902182B2 (en) * 2005-11-16 2011-03-08 Bristol-Myers Squibb Company HIV integrase inhibitors
WO2007064316A1 (fr) * 2005-11-30 2007-06-07 Bristol-Myers Squibb Company Heterocycles bicycliques en tant qu'inhibiteurs de l'integrase du vih
WO2007064502A1 (fr) * 2005-12-01 2007-06-07 Bristol-Myers Squibb Company Formes du n-[(4-fluorophényl)méthyl]-4,6,7,9-tétrahydro-3-hydroxy-9,9-diméthyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide
US20070129379A1 (en) * 2005-12-01 2007-06-07 Bristol-Myers Squibb Company Hiv integrase inhibitors
US7897593B2 (en) * 2006-05-30 2011-03-01 Bristol-Myers Squibb Company HIV integrase inhibitors
US7893055B2 (en) * 2006-06-28 2011-02-22 Bristol-Myers Squibb Company HIV integrase inhibitors
JP2009543865A (ja) * 2006-07-19 2009-12-10 ユニバーシティ オブ ジョージア リサーチ ファウンデーション， インコーポレーテッド ピリジノンジケト酸：併用療法におけるｈｉｖ複製の阻害剤
US7763630B2 (en) * 2007-06-06 2010-07-27 Bristol-Myers Squibb Company HIV integrase inhibitors
US8129398B2 (en) * 2008-03-19 2012-03-06 Bristol-Myers Squibb Company HIV integrase inhibitors
US7968541B2 (en) * 2008-03-27 2011-06-28 Bristol-Myers Squibb Company Crystalline form of N-[[4-fluoro-2-(5-methyl-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-C][1,4]-oxazine-2-carboxamide, sodium salt monohydrate
BRPI0920605A8 (pt) * 2008-10-06 2016-04-26 Merck Sharp & Dohme Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para o tratamento ou profilaxia de infecção pelo hiv ou para o tratamento, profilaxia, ou retardo no início ou progressão da aids em um paciente em necessidade deste.
US8143244B2 (en) * 2009-02-26 2012-03-27 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
CN102574854B (zh) 2009-10-13 2014-04-16 伊兰科动物健康爱尔兰有限公司 大环整合酶抑制剂
US8383639B2 (en) * 2009-10-15 2013-02-26 Bristol-Myers Squibb Company HIV integrase inhibitors
MX2012006485A (es) 2009-12-07 2012-08-23 Univ Georgia Piridinon hidroxiclicopentil carboxamidas: inhibidores de la integrasa del vih con aplicaciones terapeuticas.
NZ627826A (en) 2010-01-27 2016-01-29 Viiv Healthcare Co Antiviral combinations involving (3s,11ar)-n-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
EP2552923B1 (fr) 2010-04-02 2014-03-26 Janssen R&D Ireland Inhibiteurs de l'intégrase macrocyclique
CN104086528A (zh) 2010-07-15 2014-10-08 拜耳知识产权有限责任公司 作为杀虫剂的新杂环化合物
US8791108B2 (en) 2011-08-18 2014-07-29 Bristol-Myers Squibb Company Inhibitors of human immunodeficiency virus replication
US9089574B2 (en) 2011-11-30 2015-07-28 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
JP2015508417A (ja) * 2012-01-26 2015-03-19 クロ コンサルティング リミテッド 神経変性障害を治療するためのジアジリジン
US9714243B2 (en) 2012-12-17 2017-07-25 Merck Sharp & Dohme Corp. 4-pyridinonetriazine derivatives as HIV integrase inhibitors
EP2986291B1 (fr) 2013-04-16 2020-05-27 Merck Sharp & Dohme Corp. Composés dérivés de 4-pyridone et leurs utilisations en tant qu'inhibiteurs de la vih intégrase
ME02977B (fr) 2013-05-17 2018-10-20 Merck Sharp & Dohme Composés hétérocycliques tricycliques fusionnés utiles en tant qu'inhibiteurs de l'intégrase du vih
US9951079B2 (en) 2013-06-13 2018-04-24 Merck Sharp & Dohme Corp. Fused tricyclic heterocyclic compounds as HIV integrase inhibitors
WO2015048363A1 (fr) 2013-09-27 2015-04-02 Merck Sharp & Dohme Corp. Dérivés de quinolizine substitués utiles en tant qu'inhibiteurs de l'integrase du vih
WO2016187788A1 (fr) 2015-05-25 2016-12-01 Merck Sharp & Dohme Corp. Composés hétérocycliques tricycliques fusionnés utiles pour traiter l'infection au vih
WO2017087257A1 (fr) 2015-11-17 2017-05-26 Merck Sharp & Dohme Corp. Dérivés de pyridotriazine amido-substitués utiles en tant qu'inhibiteurs de l'intégrase du vih
EP3389380B1 (fr) 2015-12-15 2021-07-21 Merck Sharp & Dohme Corp. Dérivés de quinolizine spirocycliques utiles en tant qu'inhibiteurs de l'intégrase du vih
WO2017113288A1 (fr) 2015-12-31 2017-07-06 Merck Sharp & Dohme Corp. Composés hétérocycliques tricycliques condensés utiles en tant qu'inhibiteurs de l'intégrase du vih
JOP20190130A1 (ar) 2016-12-02 2019-06-02 Merck Sharp & Dohme مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
RU2749043C2 (ru) 2016-12-02 2021-06-03 Мерк Шарп И Доум Корп. Трициклические гетероциклические соединения, полезные в качестве ингибиторов интегразы вич
EP3573984A4 (fr) 2017-01-26 2020-07-29 Merck Sharp & Dohme Corp. Dérivés de quinolizine substitués utiles en tant qu'inhibiteurs de l'intégrase du vih
WO2021050555A1 (fr) * 2019-09-10 2021-03-18 X-Chem, Inc. Compositions et leurs utilisations
CN113912622B (zh) * 2020-07-10 2023-12-01 上海纽思克生物科技有限公司 三环嘧啶酮类化合物、其制备方法、其组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161337A0 (en) 2001-10-26 2004-09-27 Angeletti P Ist Richerche Bio N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
DK1441734T3 (da) 2001-10-26 2007-06-11 Angeletti P Ist Richerche Bio Dihydroxypyrimidin-carboxamid-inhibitorer a HIV-integrase
WO2004002406A2 (fr) * 2002-06-26 2004-01-08 Bristol-Myers Squibb Company Pyrimidinones bicycliques inhibiteurs de la cascade de coagulation
KR20050087865A (ko) 2002-12-27 2005-08-31 이스티투토 디 리세르쉐 디 비올로지아 몰레콜라레 피. 안젤레티에스.피.에이. ＨＩＶ 인테그라제 억제제로서 유용한테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘 및 관련화합물
AR046938A1 (es) 2003-12-12 2006-01-04 Merck & Co Inc Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
TW200526635A (en) 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
KR20070085702A (ko) 2004-12-03 2007-08-27 머크 앤드 캄파니 인코포레이티드 Ｕｇｔ1ａ1에 의해 대사된 약물의 약력학을 개선시키기위한 아타자나비르의 용도
CN101146811B (zh) 2005-03-31 2012-01-11 P.安杰莱蒂分子生物学研究所 Hiv整合酶抑制剂

Also Published As

Publication number Publication date
JP2008501018A (ja) 2008-01-17
SI1749011T1 (sl) 2009-08-31
EP1749011B1 (fr) 2008-10-29
AU2005250356B2 (en) 2011-03-17
RS50700B (sr) 2010-06-30
US7511037B2 (en) 2009-03-31
TW200600503A (en) 2006-01-01
CA2568356A1 (fr) 2005-12-15
BRPI0511623A (pt) 2008-03-11
NZ551282A (en) 2009-05-31
AU2005250356A1 (en) 2005-12-15
US20050267105A1 (en) 2005-12-01
DK1749011T3 (da) 2009-02-16
CY1110266T1 (el) 2015-01-14
ATE412656T1 (de) 2008-11-15
HRP20090005T3 (en) 2009-02-28
PT1749011E (pt) 2008-11-27
RU2006146970A (ru) 2008-07-10
IL179455A0 (en) 2007-05-15
DE602005010690D1 (de) 2008-12-11
CA2568356C (fr) 2012-07-03
PL1749011T3 (pl) 2009-04-30
ES2315875T3 (es) 2009-04-01
JP4874959B2 (ja) 2012-02-15
WO2005118593A1 (fr) 2005-12-15
HK1107343A1 (en) 2008-04-03
US7176196B2 (en) 2007-02-13
AR049124A1 (es) 2006-06-28
AU2005250356C1 (en) 2011-10-06
IL179455A (en) 2011-10-31
EP1749011A1 (fr) 2007-02-07
PE20060242A1 (es) 2006-03-31
KR20070039502A (ko) 2007-04-12
MXPA06013835A (es) 2007-02-02
US20060276466A1 (en) 2006-12-07
KR101097623B1 (ko) 2011-12-22
RU2381228C2 (ru) 2010-02-10
TWI366567B (en) 2012-06-21

Similar Documents

Publication Publication Date Title
NO20065879L (no) Bisykliske heterosykler som HIV-integraseinhibitorer
NO20082135L (no) HIV integrase inhibitorer
NO20081935L (no) HIV-integraseinhibitorer
NO20080797L (no) Bicykliske heterocykler som HIV Integrase inhibitorer
WO2008002959A3 (fr) Inhibiteurs de l'intégrase du vih
WO2007059125A3 (fr) Inhibiteurs de l'integrase du vih
NO20065443L (no) HIV-Integraseinhibitorer: Sykliske pyrimidinonforbindelser
MX2010009995A (es) Heterociclos puenteados como inhibidores de la integrasa del virus de inmunodeficiencia humana.
NO20090202L (no) Prolylhydroksylaseinhibitorer
WO2004096128A3 (fr) Inhibiteurs de l'integrase du vih
NO20070137L (no) Heterocykliske antivirale forbindelser
WO2005115398A3 (fr) Inhibiteurs d'integrase de vih
NO20083585L (no) Hetero-bisykliske antivirale forbindelser
DE602006020152D1 (de) Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion
TW200635918A (en) Pharmaceutical compounds
NO20085217L (no) Effektive pyrimidinderivater i behandlingen av kreft
EA201391670A1 (ru) 1,3-оксазины в качестве ингибиторов bace1 и/или bace2
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
GB0612423D0 (en) Therapeutic agents
ATE384061T1 (de) Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
ATE423122T1 (de) Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
MX2012002542A (es) Compuestos y composiciones como inhibidores de cinasa de proteina.
IL180495A (en) Benzyl triazolone compounds as non-nucleotide reverse transcriptase inhibitors
EA200802007A1 (ru) Соединения, потенцирующие рецептор амра, и применение указанных соединений в медицине

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application